LXRX
Lexicon Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
LXRX fundamentals
During Q4 2025, Lexicon Pharmaceuticals (LXRX) reported revenue of 5.49M, a YoY change of -79.31%. Net income was -15.53M, a YoY change of 54.01%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2015 | Q3,2015 | Q4,2015 | Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Apr 1, 2015 | Jul 1, 2015 | Oct 1, 2015 | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Jun 30, 2015 | Sep 30, 2015 | Dec 31, 2015 | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 376.00K -- | 566.00K -- | 127.28M -- | 12.49M -- | 20.09M +5242.82% | 27.72M +4797.00% | 18.96M -85.11% | 18.29M +46.41% | 12.05M -40.00% | 26.94M -2.80% | 34.40M +81.48% | 25.37M +38.71% | 13.80M +14.48% | 6.97M -74.14% | 17.07M -50.38% | 9.22M -63.68% | 9.68M -29.83% | 294.45M +4126.93% | 8.73M -48.88% | 8.00M -13.21% | 9.16M -5.36% | 6.63M -97.75% | 232.00K -97.34% | 27.00K -99.66% | 234.00K -97.45% | 23.00K -99.65% | 14.00K -93.97% | 37.00K +37.04% | 35.00K -85.04% | 39.00K +69.57% | 28.00K +100.00% | 24.00K -35.14% | 317.00K +805.71% | 162.00K +315.38% | 702.00K +2407.14% | 1.13M +4608.33% | 1.65M +419.56% | 1.75M +980.25% | 26.55M +3682.62% | 1.26M +11.68% | 28.87M +1652.64% | 14.18M +710.40% | 5.49M -79.31% | 49.80M -- |
Sales and Services Revenue | 376.00K -- | 566.00K -- | 127.28M -- | 12.49M -- | 20.09M +5242.82% | 27.72M +4797.00% | 18.96M -85.11% | 18.29M +46.41% | 12.05M -40.00% | 26.94M -2.80% | 34.40M +81.48% | 25.37M +38.71% | 13.80M +14.48% | 6.97M -74.14% | 17.07M -50.38% | 9.22M -63.68% | 9.68M -29.83% | 294.45M +4126.93% | 8.73M -48.88% | 8.00M -13.21% | 9.16M -5.36% | 6.63M -97.75% | -359.00K -104.11% | 27.00K -99.66% | 234.00K -97.45% | 23.00K -99.65% | -284.00K +20.89% | 37.00K +37.04% | 35.00K -85.04% | 39.00K +69.57% | -111.00K +60.92% | 24.00K -35.14% | 317.00K +805.71% | 162.00K +315.38% | 702.00K +732.43% | 1.13M +4608.33% | 1.65M +419.56% | 1.75M +980.25% | 26.55M +3682.62% | 1.26M +11.68% | 28.87M +1652.64% | 14.18M +710.40% | 5.49M -79.31% | 49.80M -- |
Other Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 558.00K -- | -- -- | -- -- | -- -- | 298.00K -46.59% | -- -- | -- -- | -- -- | 139.00K -53.36% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | 225.00K -- | 537.00K -- | 599.00K -- | 538.00K -- | 533.00K +136.89% | 838.00K +56.05% | 551.00K -8.01% | 569.00K +5.76% | 553.00K +3.75% | 1.33M +58.35% | 577.00K +4.72% | 774.00K +36.03% | 568.00K +2.71% | 728.00K -45.14% | 633.00K +9.71% | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | 0 -- | -- -- | 0 -- | 8.00K -- | 7.00K -- | 70.00K -- | 31.00K -- | 166.00K +1975.00% | 71.00K +914.29% | 348.00K +397.14% | 30.00K -3.23% | 33.00K -80.12% | 10.00K -85.92% | 201.00K -42.24% | 274.00K -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 1.90M -- | -- -- | -- -- | -- -- | 2.49M +31.17% | -- -- | -- -- | -- -- | 3.23M +29.71% | -- -- | -- -- | -- -- | 1.93M -40.30% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 7.00K -- | 70.00K -- | 31.00K -- | 166.00K -- | 71.00K +914.29% | 348.00K +397.14% | 30.00K -3.23% | 33.00K -80.12% | 10.00K -85.92% | 201.00K -42.24% | 274.00K -- |
Gross Profit | 376.00K -- | 566.00K -- | 127.28M -- | 12.49M -- | 20.09M +5242.82% | 27.72M +4797.00% | 18.96M -85.11% | 18.07M +44.61% | 11.52M -42.68% | 26.34M -4.96% | 33.86M +78.64% | 24.84M +37.49% | 12.96M +12.54% | 6.42M -75.65% | 16.50M -51.27% | 8.66M -65.13% | 8.36M -35.53% | 293.87M +4481.00% | 7.95M -51.81% | 7.43M -14.22% | 8.44M +0.96% | 6.00M -97.96% | 199.00K -97.50% | 27.00K -99.64% | 234.00K -97.23% | 23.00K -99.62% | 14.00K -92.96% | 37.00K +37.04% | 35.00K -85.04% | 39.00K +69.57% | 28.00K +100.00% | 24.00K -35.14% | 309.00K +782.86% | 155.00K +297.44% | 632.00K +2157.14% | 1.10M +4479.17% | 1.48M +379.29% | 1.68M +983.23% | 26.21M +4046.52% | 1.23M +12.10% | 28.83M +1846.86% | 14.17M +744.07% | 5.29M -79.81% | 49.53M -- |
Other Operating Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 703.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 132.59M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 27.06M -- | 34.24M -- | 38.92M -- | 46.37M -- | 57.11M +111.02% | 62.65M +82.96% | 41.01M +5.36% | 58.45M +26.07% | 45.41M -20.49% | 55.86M -10.84% | 58.59M +42.89% | 62.55M +7.02% | 43.23M -4.79% | 29.34M -47.47% | 28.87M -50.73% | 26.13M -58.22% | 26.90M -37.78% | 69.19M +135.82% | 55.17M +91.10% | 69.87M +167.37% | 73.01M +171.43% | 52.14M -24.64% | 7.42M -86.54% | 20.87M -70.14% | 18.19M -75.08% | 22.98M -55.92% | 25.34M +241.38% | 23.42M +12.23% | 24.04M +32.15% | 23.13M +0.65% | 30.31M +19.58% | 31.17M +33.09% | 44.55M +85.30% | 49.79M +115.21% | 47.37M +56.30% | 46.43M +48.98% | 56.84M +27.58% | 65.37M +31.31% | 58.94M +24.43% | 26.91M -42.04% | 25.10M -55.84% | 26.36M -59.68% | 20.07M -65.95% | 98.44M -- |
Selling, General and Administrative Expenses | 6.31M -- | 5.38M -- | 6.45M -- | 8.40M -- | 8.42M +33.44% | 12.26M +127.98% | 14.08M +118.36% | 14.87M +77.08% | 18.48M +119.52% | 16.72M +36.38% | 16.02M +13.79% | 14.86M -0.09% | 16.75M -9.31% | 15.58M -6.85% | 16.56M +3.38% | 14.11M -5.03% | 14.26M -14.87% | 13.90M -10.79% | 14.56M -12.07% | 14.69M +4.10% | 14.11M -1.05% | 12.00M -13.68% | 6.43M -55.84% | 8.26M -43.78% | 7.94M -43.77% | 7.30M -39.13% | 8.85M +37.53% | 8.49M +2.83% | 10.69M +34.65% | 12.58M +72.22% | 16.33M +84.59% | 19.14M +125.42% | 30.01M +180.82% | 32.23M +156.25% | 32.61M +99.69% | 32.06M +67.50% | 39.19M +30.61% | 39.59M +22.85% | 32.26M -1.07% | 11.61M -63.79% | 9.35M -76.14% | 7.60M -80.80% | 8.76M -72.85% | 37.32M -- |
Research and Development Expenses | 20.77M -- | 23.11M -- | 30.44M -- | 37.00M -- | 48.22M +132.15% | 52.53M +127.31% | 26.22M -13.86% | 43.58M +17.78% | 26.93M -44.14% | 39.14M -25.50% | 42.57M +62.34% | 47.70M +9.44% | 26.48M -1.70% | 13.76M -64.83% | 12.31M -71.09% | 12.02M -74.79% | 12.64M -52.27% | 26.66M +93.70% | 40.61M +229.94% | 55.18M +359.00% | 57.30M +353.44% | 40.15M +50.59% | 992.00K -97.56% | 12.61M -77.15% | 10.26M -82.10% | 15.68M -60.94% | 16.50M +1563.10% | 14.93M +18.38% | 13.36M +30.21% | 10.56M -32.68% | 13.98M -15.28% | 12.03M -19.43% | 14.54M +8.87% | 17.56M +66.32% | 14.76M +5.62% | 14.37M +19.51% | 17.64M +21.33% | 25.78M +46.83% | 26.68M +80.77% | 15.30M +6.48% | 15.75M -10.75% | 18.76M -27.24% | 11.31M -57.60% | 61.12M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 28.64M -- | -- -- | -- -- | -- -- | 1.60M -94.41% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Loss on Disposal of Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | -12.00K -- | 5.75M -- | 2.03M -- | 965.00K -- | 478.00K +4083.33% | -2.15M -137.30% | 703.00K -65.37% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 28.64M -- | -28.64M -- | -- -- | 1.60M -- | 0 -100.00% | -1.60M +94.41% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -26.69M -- | -33.68M -- | 88.36M -- | -33.87M -- | -37.02M -38.72% | -34.93M -3.73% | -21.35M -124.16% | -40.38M -19.23% | -33.89M +8.45% | -29.52M +15.50% | -24.73M -15.84% | -37.71M +6.62% | -30.27M +10.68% | -22.93M +22.33% | -12.37M +49.98% | -17.47M +53.68% | -18.55M +38.74% | 224.68M +1079.96% | -47.22M -281.77% | -62.44M -257.42% | -64.58M -248.23% | -46.14M -120.54% | 125.36M +365.50% | -20.84M +66.62% | -17.96M +72.19% | -22.96M +50.24% | -25.33M -120.21% | -23.38M -12.19% | -24.01M -33.68% | -23.09M -0.58% | -30.28M -19.53% | -31.14M -33.20% | -44.24M -84.28% | -49.63M -114.90% | -46.74M -54.36% | -45.33M -45.57% | -55.35M -25.12% | -63.69M -28.33% | -32.74M +29.95% | -25.68M +43.35% | 3.74M +106.75% | -12.19M +80.87% | -14.78M +54.85% | -48.91M -- |
Non-Operating Income (Loss) | -1.39M -- | -1.60M -- | -1.61M -- | -1.01M -- | -1.09M +21.28% | -1.08M +32.59% | -1.09M +32.36% | -3.16M -212.15% | -1.17M -6.87% | -1.20M -11.28% | -1.60M -47.11% | -4.11M -30.04% | -4.28M -266.81% | -4.47M -271.18% | -4.42M -175.59% | -4.33M -5.36% | -4.47M -4.58% | -4.60M -3.02% | -3.92M +11.19% | -4.17M +3.58% | -4.49M -0.42% | 128.75M +2896.39% | -130.85M -3237.29% | -119.00K +97.15% | -108.00K +97.60% | -160.00K -100.12% | -281.00K +99.79% | -96.00K +19.33% | -580.00K -437.04% | -292.00K -82.50% | -216.00K +23.13% | -792.00K -725.00% | -664.00K -14.48% | -894.00K -206.16% | -3.02M -1297.69% | -3.06M -286.87% | 1.93M +389.91% | -1.12M -25.06% | -1.03M +65.92% | 384.00K +112.53% | -484.00K -125.14% | -582.00K +47.94% | -750.00K +27.11% | -1.43M -- |
Other Non-Operating Income (Loss) | 269.00K -- | 82.00K -- | 68.00K -- | 637.00K -- | 547.00K +103.35% | 564.00K +587.80% | -1.75M -2670.59% | -1.57M -346.62% | 448.00K -18.10% | 415.00K -26.42% | -1.39M +20.31% | 1.00M +163.97% | 910.00K +103.13% | 783.00K +88.67% | -2.70M -93.68% | 789.00K -21.49% | 691.00K -24.07% | 600.00K -23.37% | -2.08M +22.91% | 958.00K +21.42% | 633.00K -8.39% | 132.86M +22044.00% | -133.45M -6315.96% | 48.00K -94.99% | 61.00K -90.36% | 11.00K -99.99% | -120.00K +99.91% | 14.00K -70.83% | 123.00K +101.64% | 572.00K +5100.00% | -709.00K -490.83% | -792.00K -5757.14% | -664.00K -639.84% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | 1.66M -- | 1.69M -- | 1.68M -- | 1.65M -- | 1.64M -1.03% | 1.65M -2.43% | -659.00K -139.27% | 1.59M -3.70% | 1.61M -1.47% | 1.62M -1.64% | 209.00K +131.71% | 5.11M +221.98% | 5.19M +221.38% | 5.25M +224.40% | 1.72M +721.53% | 5.12M +0.08% | 5.16M -0.44% | 5.20M -0.91% | 1.84M +7.22% | 5.13M +0.27% | 5.13M -0.76% | 4.12M -20.87% | -2.60M -241.06% | 167.00K -96.75% | 169.00K -96.70% | 171.00K -95.85% | 161.00K +106.20% | 110.00K -34.13% | 703.00K +315.98% | 864.00K +405.26% | -493.00K -406.21% | -- -- | -- -- | 894.00K +3.47% | 3.02M +712.37% | 3.06M -- | -1.93M -- | 1.12M +25.06% | 1.03M -65.92% | -384.00K -112.53% | 484.00K +125.14% | 582.00K -47.94% | 750.00K -27.11% | 1.43M -- |
Interest Expense | 1.66M -- | 1.69M -- | 1.68M -- | 1.65M -- | 1.64M -1.03% | 1.65M -2.43% | 1.63M -2.62% | 1.59M -3.70% | 1.61M -1.47% | 1.62M -1.64% | 2.16M +32.37% | 5.11M +221.98% | 5.19M +221.38% | 5.25M +224.40% | 5.22M +141.56% | 5.12M +0.08% | 5.16M -0.44% | 5.20M -0.91% | 5.19M -0.65% | 5.13M +0.27% | 5.13M -0.76% | 4.12M -20.87% | 170.00K -96.73% | 167.00K -96.75% | 169.00K -96.70% | 171.00K -95.85% | 295.00K +73.53% | 110.00K -34.13% | 703.00K +315.98% | 864.00K +405.26% | 1.10M +273.90% | -- -- | -- -- | 3.90M +351.27% | 5.42M +391.48% | 4.95M -- | 2.21M -- | 4.56M +17.00% | 3.86M -28.83% | 1.83M -62.91% | 2.32M +4.84% | 2.15M -52.76% | 2.03M -47.36% | 8.34M -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 2.29M -- | -- -- | -- -- | -- -- | 1.95M -14.78% | -- -- | -- -- | -- -- | 3.51M +79.53% | -- -- | -- -- | -- -- | 3.35M -4.50% | -- -- | -- -- | -- -- | 2.77M -17.40% | -- -- | -- -- | -- -- | 134.00K -95.16% | -- -- | -- -- | -- -- | 1.60M +1091.04% | -- -- | -- -- | 3.00M -- | 2.40M +50.50% | 1.88M -- | 4.14M -- | 3.44M +14.61% | 2.83M +17.78% | 2.22M +17.78% | 1.83M -55.66% | 1.57M -54.33% | 1.28M -54.72% | 6.91M -- |
Pretax Income From Continuing Operations | -28.07M -- | -35.28M -- | 86.75M -- | -34.88M -- | -38.11M -35.76% | -36.02M -2.08% | -22.43M -125.86% | -43.54M -24.83% | -35.06M +8.01% | -30.72M +14.70% | -26.33M -17.36% | -41.82M +3.96% | -34.55M +1.45% | -27.40M +10.83% | -16.78M +36.26% | -21.80M +47.88% | -23.02M +33.38% | 220.07M +903.30% | -51.14M -204.70% | -66.61M -205.60% | -69.07M -200.07% | 82.60M -62.47% | -5.50M +89.25% | -20.96M +68.54% | -18.07M +73.84% | -23.12M -127.99% | -25.61M -366.08% | -23.48M -12.01% | -24.59M -36.09% | -23.39M -1.15% | -30.49M -19.07% | -31.93M -36.03% | -44.90M -82.63% | -50.52M -116.04% | -49.76M -63.17% | -48.40M -51.55% | -53.43M -18.98% | -64.81M -28.28% | -33.77M +32.14% | -25.30M +47.73% | 3.25M +106.09% | -12.77M +80.30% | -15.53M +54.01% | -50.34M -- |
Income Tax Expense | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -8.65M -- | -- -- | -- -- | -4.01M -- | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -6.01M -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -28.07M -- | -35.28M -- | 86.75M -- | -34.88M -- | -38.11M -35.76% | -36.02M -2.08% | -22.43M -125.86% | -34.89M -0.02% | -35.06M +8.01% | -30.72M +14.70% | -22.32M +0.51% | -41.82M -19.86% | -34.55M +1.45% | -27.40M +10.83% | -16.78M +24.81% | -21.80M +47.88% | -23.02M +33.38% | 226.09M +925.25% | -51.14M -204.70% | -66.61M -205.60% | -69.07M -200.07% | 82.60M -63.46% | -5.50M +89.25% | -20.96M +68.54% | -18.07M +73.84% | -23.12M -127.99% | -25.61M -366.08% | -23.48M -12.01% | -24.59M -36.09% | -23.39M -1.15% | -30.49M -19.07% | -31.93M -36.03% | -44.90M -82.63% | -50.52M -116.04% | -49.76M -63.17% | -48.40M -51.55% | -53.43M -18.98% | -64.81M -28.28% | -33.77M +32.14% | -25.30M +47.73% | 3.25M +106.09% | -12.77M +80.30% | -15.53M +54.01% | -50.34M -- |
Net Income Attributable to Owners of the Company | -28.07M -- | -35.28M -- | 86.75M -- | -34.88M -- | -38.11M -35.76% | -36.02M -2.08% | -22.43M -125.86% | -34.89M -0.02% | -35.06M +8.01% | -30.72M +14.70% | -22.32M +0.51% | -41.82M -19.86% | -34.55M +1.45% | -27.40M +10.83% | -16.78M +24.81% | -21.80M +47.88% | -23.02M +33.38% | 226.09M +925.25% | -51.14M -204.70% | -66.61M -205.60% | -69.07M -200.07% | 82.60M -63.46% | -5.50M +89.25% | -20.96M +68.54% | -18.07M +73.84% | -23.12M -127.99% | -25.61M -366.08% | -23.48M -12.01% | -24.59M -36.09% | -23.39M -1.15% | -30.49M -19.07% | -31.93M -36.03% | -44.90M -82.63% | -50.52M -116.04% | -49.76M -63.17% | -48.40M -51.55% | -53.43M -18.98% | -64.81M -28.28% | -33.77M +32.14% | -25.30M +47.73% | 3.25M +106.09% | -12.77M +80.30% | -15.53M +54.01% | -50.34M -- |
Net Income Attributable to Common Stockholders | -28.07M -- | -35.28M -- | 86.75M -- | -34.88M -- | -38.11M -35.76% | -36.02M -2.08% | -22.43M -125.86% | -34.89M -0.02% | -35.06M +8.01% | -30.72M +14.70% | -22.32M +0.51% | -41.82M -19.86% | -34.55M +1.45% | -27.40M +10.83% | -16.78M +24.81% | -21.80M +47.88% | -23.02M +33.38% | 226.09M +925.25% | -51.14M -204.70% | -66.61M -205.60% | -69.07M -200.07% | 82.60M -63.46% | -5.50M +89.25% | -20.96M +68.54% | -18.07M +73.84% | -23.12M -127.99% | -25.61M -366.08% | -23.48M -12.01% | -24.59M -36.09% | -23.39M -1.15% | -30.49M -19.07% | -31.93M -36.03% | -44.90M -82.63% | -50.52M -116.04% | -49.76M -63.17% | -48.40M -51.55% | -53.43M -18.98% | -64.81M -28.28% | -33.77M +32.14% | -25.30M +47.73% | 3.25M +106.09% | -12.77M +80.30% | -15.53M +54.01% | -50.34M -- |
Other Comprehensive Income | 75.00K -- | -40.00K -- | -277.00K -- | 516.00K -- | 39.00K -48.00% | -258.00K -545.00% | -273.00K +1.44% | -69.00K -113.37% | 50.00K +28.21% | 151.00K +158.53% | -159.00K +41.76% | -172.00K -149.28% | 176.00K +252.00% | 147.00K -2.65% | 59.00K +137.11% | 45.00K +126.16% | 53.00K -69.89% | -50.00K -134.01% | 48.00K -18.64% | 776.00K +1624.44% | -548.00K -1133.96% | -277.00K -454.00% | -41.00K -185.42% | 11.00K -98.58% | -10.00K +98.18% | -- -- | -5.00K +87.80% | -27.00K -345.45% | -113.00K -1030.00% | -341.00K -- | 63.00K +1360.00% | 265.00K +1081.48% | 63.00K +155.75% | -13.00K +96.19% | 144.00K +128.57% | -81.00K -130.57% | -143.00K -326.98% | 542.00K +4269.23% | -230.00K -259.72% | -94.00K -16.05% | -39.00K +72.73% | 43.00K -92.07% | 1.00K +100.43% | -89.00K -- |
Total Comprehensive Income | -28.00M -- | -35.32M -- | 86.47M -- | -34.37M -- | -38.07M -35.98% | -36.27M -2.69% | -22.71M -126.26% | -34.96M -1.73% | -35.01M +8.05% | -30.57M +15.72% | -22.48M +1.00% | -41.99M -20.11% | -34.37M +1.82% | -27.25M +10.87% | -16.72M +25.60% | -21.75M +48.20% | -22.96M +33.19% | 226.04M +929.52% | -51.09M -205.49% | -65.83M -202.66% | -69.62M -203.15% | 82.33M -63.58% | -5.54M +89.16% | -20.95M +68.18% | -18.08M +74.03% | -23.12M -128.09% | -25.62M -362.72% | -23.50M -12.20% | -24.70M -36.64% | -23.73M -2.62% | -30.43M -18.80% | -31.67M -34.74% | -44.84M -81.54% | -50.54M -112.99% | -49.61M -63.03% | -48.48M -53.08% | -53.57M -19.47% | -64.27M -27.17% | -34.00M +31.48% | -25.39M +47.63% | 3.21M +106.00% | -12.73M +80.20% | -15.53M +54.32% | -50.43M -- |
Total Comprehensive Income Attributable to Owners of the Company | -28.00M -- | -35.32M -- | 86.47M -- | -34.37M -- | -38.07M -35.98% | -36.27M -2.69% | -22.71M -126.26% | -34.96M -1.73% | -35.01M +8.05% | -30.57M +15.72% | -22.48M +1.00% | -41.99M -20.11% | -34.37M +1.82% | -27.25M +10.87% | -16.72M +25.60% | -21.75M +48.20% | -22.96M +33.19% | 226.04M +929.52% | -51.09M -205.49% | -65.83M -202.66% | -69.62M -203.15% | 82.33M -63.58% | -5.54M +89.16% | -20.95M +68.18% | -18.08M +74.03% | -23.12M -128.09% | -25.62M -362.72% | -23.50M -12.20% | -24.70M -36.64% | -23.73M -2.62% | -30.43M -18.80% | -31.67M -34.74% | -44.84M -81.54% | -50.54M -112.99% | -49.61M -63.03% | -48.48M -53.08% | -53.57M -19.47% | -64.27M -27.17% | -34.00M +31.48% | -25.39M +47.63% | 3.21M +106.00% | -12.73M +80.20% | -15.53M +54.32% | -50.43M -- |
Basic EPS | -0.27 -- | -0.34 -- | -- -- | -0.34 -- | -0.37 -37.04% | -0.35 -2.94% | -0.22 -- | -0.33 +2.94% | -0.33 +10.81% | -0.29 +17.14% | -0.21 +4.55% | -0.4 -21.21% | -0.33 -- | -0.26 +10.34% | -0.16 +23.81% | -0.21 +47.50% | -0.22 +33.33% | 2.13 +919.23% | -0.48 -200.00% | -0.63 -200.00% | -0.65 -195.45% | 0.77 -63.85% | -0.04 +91.67% | -0.15 +76.19% | -0.13 +80.00% | -0.16 -120.78% | -0.17 -325.00% | -0.16 -6.67% | -0.16 -23.08% | -0.13 +18.75% | -0.16 +5.88% | -0.17 -6.25% | -0.22 -37.50% | -0.21 -61.54% | -0.2 -25.00% | -0.2 -17.65% | -0.17 +22.73% | -0.18 +14.29% | -0.09 +55.00% | -0.07 +65.00% | 0.01 +105.88% | -0.04 +77.78% | -0.04 +55.56% | -0.14 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.21 -- | -- -- | -0.2 -- | -0.17 -- | -0.18 +14.29% | -- -- | -0.07 +65.00% | 0.01 +105.88% | -0.04 +77.78% | -- -- | -- -- |
Diluted EPS | -0.27 -- | -0.34 -- | -- -- | -0.34 -- | -0.37 -37.04% | -0.35 -2.94% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.33 -- | -0.26 -- | -- -- | -0.21 -- | -0.22 +33.33% | 1.95 +850.00% | -- -- | -0.63 -200.00% | -0.65 -195.45% | 0.71 -63.59% | -- -- | -0.15 +76.19% | -0.13 +80.00% | -0.16 -122.54% | -- -- | -0.16 -6.67% | -0.16 -23.08% | -0.13 +18.75% | -- -- | -0.17 -6.25% | -0.22 -37.50% | -0.21 -61.54% | -- -- | -0.2 -17.65% | -0.17 +22.73% | -0.18 +14.29% | -- -- | -0.07 +65.00% | 0.01 +105.88% | -0.04 +77.78% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.21 -- | -- -- | -0.2 -- | -0.17 -- | -0.18 +14.29% | -- -- | -0.07 +65.00% | 0.01 +105.88% | -0.04 +77.78% | -- -- | -- -- |
You can ask Aime
What factors drove the changes in Lexicon Pharmaceuticals's revenue and profit?What is the revenue and EPS growth rate for Lexicon Pharmaceuticals year over year?What does Lexicon Pharmaceuticals do and what are its main business segments?What is Lexicon Pharmaceuticals's gross profit margin?What were the key takeaways from Lexicon Pharmaceuticals’s earnings call?Did Lexicon Pharmaceuticals beat or miss consensus estimates last quarter?What guidance did Lexicon Pharmaceuticals's management provide for the next earnings period?What were the key takeaways from Lexicon Pharmaceuticals's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
